IFOSFAMIDE for Embryonal rhabdomyosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 116 adverse event reports in the FDA FAERS database where IFOSFAMIDE was used for Embryonal rhabdomyosarcoma.

Most Reported Side Effects for IFOSFAMIDE

Side Effect	Reports	%	Deaths	Hosp.
Off label use	2,281	13.4%	486	629
Febrile neutropenia	2,225	13.1%	228	1,165
Disease progression	1,912	11.2%	515	198
Neutropenia	1,509	8.9%	173	417
Drug ineffective	1,331	7.8%	416	317
Thrombocytopenia	1,227	7.2%	140	317
Anaemia	1,067	6.3%	94	365
Product use in unapproved indication	890	5.2%	190	183
Pyrexia	752	4.4%	107	493
Sepsis	712	4.2%	406	273
Malignant neoplasm progression	671	4.0%	210	120
Infection	649	3.8%	177	113
Pancytopenia	632	3.7%	144	270
Encephalopathy	585	3.4%	72	287
Vomiting	570	3.4%	80	274